ADC Therapeutics
Isabel Coldani-Perez has extensive experience in accounts payable and administration, currently serving as Senior Manager of Accounts Payable & Administration at ADC Therapeutics since May 2015, where leadership over a team of three accountants is maintained. Previous roles include Accounts Payable Analyst at Alexion Pharmaceuticals, Inc., and Accounts Payable Specialist positions at O-I and various consulting firms, focusing on invoice management and discrepancy resolution. Isabel's educational background includes a Post Graduate degree in Human Resources Management from Euncet Business School, a Master’s in Occupational Health & Safety Risk Management from the Official School of Mines Engineering, and a Bachelor’s degree in Labor Law from the Autonomous University of Barcelona, complemented by certifications in administrative management and secretarial science.
This person is not in any teams
This person is not in any offices
ADC Therapeutics
2 followers
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.